Design and evaluation of osmotic pump-based controlled release system of Ambroxol Hydrochloride

Pharmaceutical Development and Technology

Volumn 16, Issue 4, 2011, Pages 392-399

  Cheng, Xiongkai ^a   Sun, Min ^a   Gao, Yan ^a   Cao, Fengliang ^a   Zhai, Guangxi ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Ambroxol Hydrochloride (Amb); In vitro release; Orthogonal design; Osmotic pump controlled release tablet; Pharmacokinetics

Indexed keywords

AMBROXOL; CITRIC ACID; ETHYL CELLULOSE; LACTOSE; MACROGOL 400; MACROGOL 6000;

ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; EXPERIMENTAL RABBIT; MEMBRANE COMPONENT; MEMBRANE PERMEABILITY; NONHUMAN; OSMOTIC PRESSURE; OSMOTIC PUMP; POROSITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TABLET FORMULATION;

AMBROXOL; ANIMALS; BIOLOGICAL AVAILABILITY; CAPSULES; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; EXPECTORANTS; LACTOSE; OSMOSIS; OSMOTIC PRESSURE; POLYETHYLENE GLYCOLS; POROSITY; RABBITS; SOLUBILITY; TABLETS;

EID: 79960222754     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837451003774385     Document Type: Article

References (28)

1. Lee HJ, Joung SK, Kim YG, Yoo JY, Han SB. Bioequivalence assessment of ambroxol tablet after a single oral dose administration to healthy male volunteers. Pharm Res 2004;49:93-98. (Pubitemid 37324909)
2. Kubo W, Miyazaki S, Dairaku M, Togashi M, Mikami R, Attwood D. Oral sustained delivery of ambroxol from in situ-gelling pectin formulations. Int J Pharm 2004;271:233-240. (Pubitemid 38210101)
3. Yang XG, Zhang GH, Li W, Peng B, Liu ZD, Pan WS. Design and evaluation of Jingzhiguanxin monolithic osmotic pump tablet. Chem Pharm Bull 2006;4:465-469.
4. Kanagale P, Lohray BB, Misra A, Davadra P, Kini R. Formulation and optimization of porous osmotic pump-based controlled release system of oxybutynin. AAPS PharmSciTech 2007;3:53.
5. Theeuwes F. Elementary osmotic pump. J Pharm Sci 1975;64:1987-1991.
6. Santus G, Baker RW. Osmotic drug delivery: A review of the patent literature. J Control Rel 1995;35:1-21.
7. Liu LX, Ku J, Khang G, Lee B, Rhee JM, Lee HB. Nifedipine controlled delivery by sandwiched osmotic tablet system. J Control Rel 2000;2:145-156. (Pubitemid 30488892)
8. Liu LX, Xu XN. Preparation of bilayer-core osmotic pump tablet by coating the indented core tablet. J Control Rel 2008;352:225-230.
9. Liu LX, Che BJ. Preparation of monolithic osmotic pump system by coating the indented core tablet. Eur J Pharm Biopharm 2006;64:180-184.
10. Prabakaran D, Singh P, Jaganathan KS, Vyas SP. Osmotically regulated asymmetric capsular systems for simultaneous sustained delivery of anti-tubercular drugs. J Control Rel 2004;2:239-248. (Pubitemid 38232673)
11. Garg A, Gupta M, Bhargava HN. Effect of formulation parameters on the release characteristics of propranolol from asymmetric membrane coated tablets. Eur J Pharm Biopharm 2007;67:725-731. (Pubitemid 47576615)
12. Philip AK, Pathak K, Shakya P. Asymmetric membrane in membrane capsules: A means for achieving delayed and osmotic flow of cefadroxil. Eur J Pharm Biopharm 2008;69:658-666.
13. Makhija SN, Vavia PR. Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine I: Cellulose acetate as a semipermeable membrane. J Control Rel 2003;89:5-18. (Pubitemid 36416615)
14. Liu LX, Khang G, Rhee JM, Lee HB. Monolithic osmotic tablet system for nifedipine delivery. J Control Rel 2000;2-3:309-322. (Pubitemid 30303844)
15. Prabakaran D, Singh P, Kanaujia P, Vyas SP. Effect of hydrophilic polymers on the release of diltiazem hydrochloride from elementary osmotic pumps. Int J Pharm 2003;259:173-179. (Pubitemid 36638563)
16. Verma RK, Garg S. Development and evaluation of osmotically controlled oral drug delivery system of glipizide. Eur J Pharm Biopharm 2004;57:513-525. (Pubitemid 38490570)
17. Liu LX, Wang XC. Solubility-modulated monolithic osmotic pump tablet for atenolol delivery. Eur J Pharm Biopharm 2008;68:298-302.
18. Jin LY, Zhang Y, Han F, Jiao CM, Li SM. Effects of coating on the in-vitro release of venlafaxine hydrochloride microporous membrane osmotic pump tablets. J Shenyang Pharm Univ 2008;25:593.
19. Zhang FY, Wu T, Pan WS, Chen JM, Zhang RH. The preparation of salbutamol sulfate controlled release tablets coated with cellulose acetate aqueous dispersion. J Chin Pharm Sci 2001;10: 85-90.
20. Ma P, Sun SY, Xin YR, Liang DM, Gao WJ. Optimizing the formulation and their process of the sustained-release Ca-alginate gel pellets of nifedipine. J Shenyang Pharm Univ 2003;20:403-408.
21. Chinese Pharmacopoeia Commission. The Pharmacopoeia of the Peoples Republic of China. Beijing: Chemical Industry Press, 2005, appendix XC: 75-76.
22. Ishikawa T, Watanabe Y, Takayama K, Endo H, Matsumoto M. Effect of hydroxypropylmethylcellulose (HPMC) on the release profiles and bioavailability of a poorly water-soluble drug from tablets prepared using macrogol and HPMC. Int J Pharm 2000;202:173-178. (Pubitemid 30466244)
23. Philip AK, Pathak K. Wet process-induced phase-transited drug delivery system: A means for achieving osmotic, controlled, and level A IVIVC for poorly water-soluble drug. Drug Dev Ind Pharm 2008;34:735-743. (Pubitemid 351962346)
24. Royce A, Li SF, Weaver M, Shah U. In vivo and in vitro evaluation of three controlled release principles of 6-N-cyclohexyl-2V -O-methyladenosine. J Control Rel 2004;97:79-90. (Pubitemid 38624511)
25. Herbig SM, Cardinal JR, Korsmeyer RW, Smith KL. Asymmetricmembrane tablet coatings for osmotic drug delivery. J Controlled Res 1995;35:127.
26. Prabakaran D, Singh P, Kanaujia P, Mishra V, Jaqanathan KS, Vyas SP. Controlled porosity osmotic pumps of highly aqueous soluble drug containing hydrophilic polymers as release retardants. Pharm Dev Technol 2004;9:435-442. (Pubitemid 39525266)
27. Thombre AG, Appel LE, Chidlaw MB, Daugherit PD, Dumont F, Evans AF, Sutton SC. Osmotic drug delivery using swellable-core technology. J Control Rel 2004;1:75-89. (Pubitemid 37542379)
28. Ryu W, Huang ZN, Prinz FB, Goodman SB, Fasching R. Biodegradable micro-osmotic pump for long-term and controlled release of basic fibroblast growth factor. J Control Rel 2007;124:98-105. (Pubitemid 350103731)